APP下载

犀角地黄汤加味治疗原发免疫性血小板减少症的效果及对T淋巴细胞亚群水平的影响

2020-12-23曾惠赵晓燕颜敏超沈明芳

中国医药导报 2020年28期

曾惠 赵晓燕 颜敏超 沈明芳

[摘要] 目的 分析犀角地黃汤加味治疗原发免疫性血小板减少症的效果及对T淋巴细胞亚群水平的影响。 方法 选取2016年1月—2018年2月浙江省嘉兴市第一医院收治的原发免疫性血小板减少症患者76例,按照随机数表法将其分为常规组和中药组,各38例。常规组采用醋酸泼尼松片治疗,中药组在常规组的基础上接受犀角(水牛角代犀角)地黄汤加味治疗。比较两组治疗后总有效率及复发率、中医症状评分、血小板计数、T淋巴细胞亚群CD3+、CD4+、CD8+水平。 结果 治疗后,两组总有效率及复发率比较,差异无统计学意义(P > 0.05)。治疗后,中药组中医症状改善的总有效率明显高于常规组,差异有统计学意义(P < 0.05)。治疗后,两组血小板计数均明显升高(P < 0.05),但两组组间比较,差异无统计学意义(P > 0.05)。治疗后,两组CD3+、CD4+水平明显升高,且中药组明显高于常规组,差异有统计学意义(P < 0.05)。治疗后,两组CD8+水平明显降低,且中药组明显低于常规组,差异有统计学意义(P < 0.05)。两组治疗期间均未出现不良反应。 结论 犀角地黄汤加味治疗原发免疫性血小板减少症效果显著,能明显改善患者的临床症状,且能改善患者T淋巴细胞亚群水平。

[关键词] 原发免疫性血小板减少症;犀角地黄汤;T淋巴细胞亚群;血小板计数

[中图分类号] R25          [文献标识码] A          [文章编号] 1673-7210(2020)10(a)-0140-04

Effect of modified Xijiao Dihuang Decoction on primary immunologic thrombocytopenic purpura and the level of T lymphocyte subsets

ZENG Hui   ZHAO Xiaoyan   YAN Minchao   SHEN Mingfang

Department of Hematology, the First Hospital of Jiaxing, Zhejiang Province, Jiaxing   314000, China

[Abstract] Objective To analyze the effect of modified Xijiao Dihuang Decoction on primary immunologic thrombocytopenic purpura and the level of T lymphocyte subsets. Methods A total of 76 patients with primary immunologic thrombocytopenic purpura admitted to the First Hospital Jiaxing from January 2016 to February 2018 were selected for this study. According to the random number table method, they were randomly divided into conventional group and traditional Chinese medicine group, 38 cases in each group. The conventional group was treated with Prednisone Acetate Tablets, while the traditional Chinese medicine group was treated with modified Xijiao Dihuang Decoction (buffalo horn instead of rhino horn). After treatment, the effects total effective rate and relapse rate, traditional Chinese medicine symptom score, platelet count and T lymphocyte subsets CD3+, CD4+ and CD8+ of the two groups were compared. Results After treatment, there was no significant difference in the total effective rate and relapse rate between the two groups (P > 0.05). After treatment, the total effective rate of traditional Chinese medicine symptom improvement in traditional Chinese medicine group was higher than that in the conventional group (P < 0.05). After treatment, the platelet count of the two groups increased (P < 0.05), but there was no significant difference between the two groups (P > 0.05). After treatment, the levels of CD3+ and CD4+ in the two groups were higher, and the traditional Chinese medicine group were higher than those in the conventional group (P < 0.05); the levels of CD8+ in the two groups were lower, and the traditional Chinese medicine group was lower than that in the conventional group (P < 0.05). There were no adverse reactions in the two groups during the study. Conclusion Modified Xijiao Dihuang Decoction has a significant effect in the treatment of primary immunologic thrombocytopenic purpura, it can obviously improve the clinical symptoms of patients and the level of T lymphocyte subsets.

[Key words] Primary immunologic thrombocytopenic purpura; Xijiao Dihuang Decoction; T lymphocyte subsets; Platelet count

原发免疫性血小板减少症属于自身免疫性疾病,也称之为特发性血小板减少性紫癜,患者血小板减少,伴或不伴出血[1-2]。免疫异常后使得机体内产生特异性的抗血小板生成减少和破坏增加,因此在实验室检查中可知患者的血小板计数明显减少[3-4]。中医认为原发免疫性血小板减少症发生的原因可分为内伤与外感两个方面,病理因素主要为瘀、虚、热,病位主要在肝、脾、肾。病机为外感邪热/血热妄行;脾气虚损,气不摄血;脾肾阳虚,统摄无权;肝肾阴虚,虚火上炎;瘀血内阻,血不循经[5]。本病……

登录APP查看全文